A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide
Status:
Terminated
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Trial to determine if seizure prophylaxis with IV LCM in NSICU patients experiencing mental
status changes due to severe traumatic brain injury (sTBI) will result in improved short- and
long-term outcomes and better immediate adverse effects when compared to the current standard
of care anticonvulsant (IV fPHT) and will be at least as effective as IV fPHT in preventing
clinical and sub-clinical seizure activity.